EGT vs. KPT, BUS, BOS, XTC, IGP, GB, PTE, INQ, PKG, and MRE
Should you be buying Eguana Technologies stock or one of its competitors? The main competitors of Eguana Technologies include KP Tissue (KPT), Grande West Transportation Group (BUS), AirBoss of America (BOS), Exco Technologies (XTC), Imperial Ginseng Products (IGP), Ginger Beef (GB), Pioneering Technology (PTE), Inscape (INQ), Packaging Co. of America (PKG), and Martinrea International (MRE). These companies are all part of the "consumer goods" sector.
Eguana Technologies vs.
KP Tissue (TSE:KPT) and Eguana Technologies (CVE:EGT) are both small-cap consumer goods companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.
KP Tissue received 197 more outperform votes than Eguana Technologies when rated by MarketBeat users. However, 66.67% of users gave Eguana Technologies an outperform vote while only 66.43% of users gave KP Tissue an outperform vote.
18.8% of KP Tissue shares are held by institutional investors. Comparatively, 8.2% of Eguana Technologies shares are held by institutional investors. 0.1% of KP Tissue shares are held by company insiders. Comparatively, 38.5% of Eguana Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
KP Tissue has a net margin of 0.00% compared to Eguana Technologies' net margin of -158.12%. KP Tissue's return on equity of -13.67% beat Eguana Technologies' return on equity.
KP Tissue presently has a consensus price target of C$10.30, suggesting a potential upside of 0.49%. Eguana Technologies has a consensus price target of C$0.55, suggesting a potential upside of 129.17%. Given Eguana Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Eguana Technologies is more favorable than KP Tissue.
Eguana Technologies has higher revenue and earnings than KP Tissue. Eguana Technologies is trading at a lower price-to-earnings ratio than KP Tissue, indicating that it is currently the more affordable of the two stocks.
KP Tissue has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Eguana Technologies has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.
In the previous week, KP Tissue's average media sentiment score of 0.00 equaled Eguana Technologies' average media sentiment score.
Summary
Eguana Technologies beats KP Tissue on 9 of the 15 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of CVE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Eguana Technologies Competitors List
